CymaBay Announces $100 Million Non-Dilutive Financing with Abingworth
Risk-sharing agreement with Abingworth will fund seladelpar Phase 3 development program for PBC CymaBay retains full worldwide commercial rights to seladelpar NEWARK, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a more...
Climb Channel Solutions Unveils Its Brand New Cloud Marketplace – Expedition
EATONTOWN, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly-owned subsidiary of Wayside Technology Group, Inc. (NASDAQ: WSTG), announces the launch of its own cloud marketplace – more...
ReWalk Robotics Appoints Senior Biotech Executive, Jeannine Lynch, as Vice President of Strategy and Market Access
Ms. Lynch will lead ongoing building and implementation of ReWalk’s market access and reimbursement programs MARLBOROUGH, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a manufacturer of robotic more...
FDA Agrees with Galmed’s Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study
FDA Agrees with Galmed’s Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study – FDA agreed that Galmed can proceed with its proposed clinical studies with Aramchol more...
Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing Agreement with Horizon Technology Finance
Achieved performance milestone with positive initial results from its Phase 1b trial of CERC-002 in moderate-to- severe Crohn’s Disease who had previously failed three or more lines of biologics therapies, including anti-TNF alpha treatments ROCKVILLE, more...
EyePoint Pharmaceuticals Announces Renowned Scientists to Join New Executive Scientific Advisory Board
Chaired by Dr. Carl Regillo, illustrious leader in retinal surgery WATERTOWN, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve more...
Identiv Appoints Amir Khoshniyati as Vice President of Business Development, Americas
Identiv Appoints Amir Khoshniyati as Vice President of Business Development, Americas Experienced NFC, IoT, and Digital Identity Executive Joins Identiv to Bolster the Company’s Growing Investment in the RFID Market PR Newswire FREMONT, Calif. , more...
1933 Industries to Hold Extraordinary Meeting of Debentureholders and Recommends Holders to Vote in Favor of the Proposed Amendment
The amendment seeks to complete the one-year extension of the maturity date of the debentures VANCOUVER, BC / ACCESSWIRE / August 2, 2021 / 1933 Industries Inc. (the “Company” or “1933 Industries“) (CSE:TGIF)(OTCQB:TGIFF), a Nevada more...
Jushi Holdings Inc. Pre-Announces Second Quarter 2021 Financial Results and Provides Earnings Conference Call Details
Revenue increased 14.6% to $47.7 million as compared to the first quarter 2021 Net Loss of $11.4 million, a $15.4 million improvement as compared to the first quarter 2021 Adjusted EBITDA (A) of $4.6 million Company more...
4Front Ventures to Report Second Quarter 2021 Financial Results on August 16, 2021
4Front Ventures to Report Second Quarter 2021 Financial Results on August 16, 2021 PR Newswire PHOENIX , Aug. 2, 2021 /PRNewswire/ – 4Front Ventures Corp . (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”), a more...